NASDAQ:TRAW

Traws Pharma Stock Insider Trading

*Your capital is at risk

$1.45

+0.0300 (+2.11%)

At Close: Jun 03, 2026

Traws Pharma Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 9.33M and sold 12.16B TRAW shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	9.33M shares
● Sell	12.16B shares
96% Buy Activity Negligible or No Correlation
Buy Signal High Confidence Apr 16, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 100. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (96% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Apr 16, 2026 Buy	Series C Warrants (right to buy) P-Purchase	Orbimed Advisors Llc 10 Percent Owner	10% Owner	1 793 187 Value: $3.00M
Apr 16, 2026 Buy	Common Stock P-Purchase	Orbimed Advisors Llc 10 Percent Owner	10% Owner	597 729 Value: $998.2K
Apr 16, 2026 Buy	Series A Warrants (right to buy) P-Purchase	Orbimed Advisors Llc 10 Percent Owner	10% Owner	597 729 Value: $1.00M
Apr 16, 2026 Buy	Series B Warrants (right to buy) P-Purchase	Orbimed Advisors Llc 10 Percent Owner	10% Owner	597 729 Value: $1.00M
Mar 08, 2026 Buy	Stock Option (right to buy) A-Award	Parker Charles Nolan Chief Financial Officer	C-Suite Officer	104 544 Value: $167.3K
Mar 08, 2026 Buy	Stock Option (right to buy) A-Award	Clarke Trafford Director	Director	33 435 Value: $53.5K
Mar 08, 2026 Buy	Stock Option (right to buy) A-Award	Cautreels Werner Director	Director	31 258 Value: $50.0K
Mar 08, 2026 Buy	Stock Option (right to buy) A-Award	Leaman John Harold Director	Director	33 435 Value: $53.5K
Mar 08, 2026 Buy	Stock Option (right to buy) A-Award	Dukes Iain D. Chief Executive Officer	CEO / President	231 336 Value: $370.1K
Mar 08, 2026 Buy	Stock Option (right to buy) A-Award	Pauza Charles David Chief Science Officer Virology	Officer	118 367 Value: $189.4K
Mar 08, 2026 Buy	Stock Option (right to buy) A-Award	Savchuk Nikolay Chief Operating Officer	C-Suite Officer	96 899 Value: $155.0K
Mar 08, 2026 Buy	Stock Option (right to buy) A-Award	Stover Jack E Director	Director	33 435 Value: $53.5K
Mar 08, 2026 Buy	Stock Option (right to buy) A-Award	Redfield Robert Chief Medical Officer	Officer	108 854 Value: $174.2K
Mar 08, 2026 Buy	Stock Option (right to buy) A-Award	Shoemaker Mary Teresa Director	Director	33 435 Value: $53.5K
Dec 12, 2025 Buy	Stock Option (right to buy) A-Award	Parker Charles Nolan Chief Financial Officer	C-Suite Officer	61 571 Value: $143.5K
Dec 12, 2025 Buy	Common Stock A-Award	Parker Charles Nolan Chief Financial Officer	C-Suite Officer	15 393 Value: $36.2K
Dec 12, 2025 Buy	Stock Option (right to purchase) A-Award	Leaman John Harold Director	Director	16 234 Value: $37.8K
Dec 12, 2025 Buy	Common Stock A-Award	Leaman John Harold Director	Director	4 058 Value: $10K
Dec 12, 2025 Buy	Stock Option (right to purchase) A-Award	Clarke Trafford Director	Director	24 629 Value: $57.4K
Dec 12, 2025 Buy	Common Stock A-Award	Clarke Trafford Director	Director	6 157 Value: $14.5K
Dec 12, 2025 Buy	Common Stock A-Award	Cautreels Werner Director	Director	4 874 Value: $11.5K
Dec 12, 2025 Buy	Stock Option (right to purchase) A-Award	Cautreels Werner Director	Director	19 496 Value: $45.4K
Dec 12, 2025 Buy	Stock Option (right to purchase) A-Award	Shoemaker Mary Teresa Director	Director	24 629 Value: $57.4K
Dec 12, 2025 Buy	Common Stock A-Award	Shoemaker Mary Teresa Director	Director	6 157 Value: $14.5K
Dec 12, 2025 Buy	Stock Option (right to purchase) A-Award	Stover Jack E Director	Director	24 629 Value: $57.4K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks